Market Signal Briefing

Lockheed Martin (LMT - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.

Over the past month, shares of this aerospace and defense company have returned -6.9%, compared to the Zacks S&P 500 composite's -0.5% change. During this period, the Zacks Aerospace - Defense industry, which Lockheed falls in, has lost 4.9%. The key question now is: What could be the stock's future direction?

While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.

Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.

Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

For the current quarter, Lockheed is expected to post earnings of $6.64 per share, indicating a change of -13.4% from the year-ago quarter. The Zacks Consensus Estimate has changed -1% over the last 30 days.

The consensus earnings estimate of $22.22 for the current fiscal year indicates a year-over-year change of -22%. This estimate has changed -0.1% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $29.7 indicates a change of +33.7% from what Lockheed is expected to report a year ago. Over the past month, the estimate has changed +0.3%.

With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Lockheed.

The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:

12 Month EPS

Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.

For Lockheed, the consensus sales estimate for the current quarter of $19.64 billion indicates a year-over-year change of +5.5%. For the current and next fiscal years, $74.4 billion and $77.59 billion estimates indicate +4.7% and +4.3% changes, respectively.

Last Reported Results and Surprise HistoryLockheed reported revenues of $18.61 billion in the last reported quarter, representing a year-over-year change of +8.8%. EPS of $6.95 for the same period compares with $6.84 a year ago.

Compared to the Zacks Consensus Estimate of $18.56 billion, the reported revenues represent a surprise of +0.28%. The EPS surprise was +9.79%.

The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates two times over this period.

ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.

Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.

Lockheed is graded B on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.

ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Lockheed. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.

Key Takeaways RTX's Pratt & Whitney secured a $1.61B contract to support F-35 propulsion systems.Work spans sustainment, repairs, technical updates and training across multiple U.S. services.Most tasks will be done in East Hartford, Oklahoma City and Indianapolis through November 2026.
RTX Corporation’s (RTX - Free Report) business segment, Pratt & Whitney, recently secured a contract to provide ongoing support for F-35 propulsion systems. The work includes sustainment services, program and product management, spare parts procurement, engineering assistance, software updates and overall material and configuration management.

Pratt & Whitney will also handle maintenance and repairs at F-35 production and operational sites, update technical data, manage support equipment and provide training for the aircraft’s propulsion systems. The contract was awarded by the Naval Air Systems Command in Patuxent River, MD.

Valued at $1.61 billion, the contract is expected to be completed by November 2026. The contract will serve the U.S. Air Force, Marine Corps, Navy and Foreign Military Sales (FMS) customers. The majority of work related to this award will be carried out in East Hartford, CT; Oklahoma City, OK; and Indianapolis, IN.

What’s Favoring RTX?With rising global geopolitical tensions, more nations are investing in technologically advanced combat jets that can perform well in difficult situations to boost their aerial security. This, in turn, has been bolstering the demand for advanced fighter jets and thereby their engines like the F135, built by RTX’s Pratt & Whitney business.

With nations across the globe striving to strengthen their aerial border, growth prospects for the fighter jet market thus remain bright. To this end, the Mordor Intelligence firm predicts that the global fighter aircraft market will witness a CAGR of 4.24% during the 2025-2030 period.

This market growth opportunity is likely to boost the demand for combat jet engines. With more than 7,500 Pratt and Whitney military engines currently in service with 30 armed forces worldwide, RTX is well-positioned to secure more contracts involving its jet engines, like the latest one, in the future.

Prospects of Other Defense StocksOther defense companies that are likely to enjoy the perks of the expanding fighter jet market have been discussed below.

Northrop Grumman (NOC - Free Report) is a leading provider of proven manned and unmanned air systems. It builds some of the world’s most advanced aircraft, like the B-2 Spirit Stealth Bomber, A-10 Thunderbolt II and B-21 Raider.

Northrop Grumman has a long-term (three to five years) earnings growth rate of 4.2%. The Zacks Consensus Estimate for NOC’s 2025 sales indicates year-over-year growth of 2.1%.

Lockheed Martin Corporation (LMT - Free Report) is the manufacturer of some of the most advanced military jets in the world. Its key jet programs include the F-35 Lightning II, F-22 Raptor, F-16 Fighting Falcon and C-130 Hercules.

Lockheed Martin has a long-term earnings growth rate of 12.4%. The consensus estimate for LMT’s 2025 sales indicates year-over-year growth of 4.7%.

 The Boeing Company (BA - Free Report) is a significant player in the fighter jet market with its F/A-18 Super Hornet and F-15 Eagle programs. These jets, which are essential in the U.S. Navy and Air Force fleet, are also exported to U.S.-allied nations.

Boeing has a long-term earnings growth rate of 31.3%. The Zacks Consensus Estimate for BA’s 2025 sales indicates year-over-year growth of 30.5%.

RTX Stock’s Price MovementShares of RTX have gained 47.3% in the past year compared with the industry’s 20.6% growth.

Image Source: Zacks Investment Research

RTX’s Zacks RankRTX currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

ERLANGER, Ky.--(BUSINESS WIRE)--Toyota Boshoku America, Inc. acquires full ownership of TBDN Tennessee Company, rebrands as Toyota Boshoku Jackson Tennessee, LLC.

Grainger plc (OTC:GRGTF) Q4 2025 Earnings Call November 25, 2025 4:00 AM EST

Company Participants

Helen Gordon - CEO & Executive Director
Robert Hudson - Group CFO & Executive Director
Kurt Mueller - Director of Corporate Affairs

Presentation

Operator

Good morning, ladies and gentlemen, and welcome to the Grainger plc Full Year Results Investor Presentation. [Operator Instructions] Before we begin, we would like to submit the following poll. And if you could give that your kind attention, I'm sure the company would be most grateful.

And I would now like to hand you over to the executive management team from Grainger plc. Helen, good morning.

Helen Gordon
CEO & Executive Director

Good morning, and thank you, everyone, for joining us this morning. I'm joined today by Rob Hudson, our CFO; and Kurt Mueller, our Head of Corporate Affairs. Last week, we presented our full year results, and they were very strong in terms of the growth in our earnings, in our income and in our margin. And what we're going to do today is take you through an abbreviated presentation and then leave plenty of time for question and answer.

One of the things that has happened to Grainger this year that we've actually delivered, we are the U.K.'s leading residential REIT. So we converted to a REIT in September. And what that means is that now -- we're free from corporate tax on our income.

We are the largest build-to-rent investor operator in the U.K. And one of our real strengths is our operational platform, which is a real barrier to entry in a business that has a high degree of customer interface. and we have a long track record of proving our earnings and our growth in value.

The one thing I would say about our underlying business is

Recommended For You

Key Takeaways Five momentum stocks are highlighted for December following mixed index performance in November.These picks show improving earnings estimates and solid business drivers for December.EXPE, ALL, DDS, KGC and GMED each carry strong momentum scores supported by recent stock price trends.
U.S. stock markets have continued their northward journey in 2025 following an impressive rally over the previous two years. Meanwhile, November saw mixed trading. The Dow and the S&P 500 Index gained 0.3% and 0.1%, respectively. However, the Nasdaq Composite fell 1.5%.

Volatility reappeared last month due to investors’ concerns about the sustainability of artificial intelligence (AI) trade. Wall Street’s rally in the past three years was solely driven by AI-centric stocks. Extremely overstretched valuation of this space makes market participants nervous regarding the space’s near-term return potential.

Nevertheless, the three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — have rallied 12.6%, 16.7% and 21.2%, respectively, year to date. This trend is likely to continue in December buoyed by another expected interest rate cut by the Fed.

At this stage, it will be prudent to invest in stocks with a favorable Zacks Rank that have momentum in December. Five such stocks are: Expedia Group Inc. (EXPE - Free Report) , The Allstate Corp. (ALL - Free Report) , Dillard's Inc. (DDS - Free Report) , Kinross Gold Corp. (KGC - Free Report) and Globus Medical Inc. (GMED - Free Report) . Each of our picks currently sports a Zacks Rank #1 (Strong Buy) and has a Zacks Momentum Score of A. You can see the complete list of today’s Zacks #1 Rank stocks here.

The chart below shows the price performance of our five picks in the past month.

Image Source: Zacks Investment Research

Expedia Group Inc.Expedia Group benefits from a strong platform model that enhances customer insights, strengthens supplier ties, and helps in revenue growth. EXPE’s diverse brand portfolio spanning major travel services enables it to target a broad range of global traveler needs, while boosting traffic and bookings. 

A broad multi-product supply network, including lodging, airlines, rental cars, and cruises, positions EXPE well to capture demand in the growing leisure travel space. Strong liquidity, share buybacks, and dividends further highlight EXPE’s financial resilience.

Expedia Group has an expected revenue and earnings growth rate of 6.3% and 20.8%, respectively, for next year. The Zacks Consensus Estimate for next year’s earnings has improved 7.9% over the last 30 days.

The Allstate Corp.The Allstate is witnessing consistent growth in premiums, thanks to strategic acquisitions and expanding ventures. ALL’s net premium earned rose 7.6% YoY in the first nine months of 2025. Its focus on optimizing core operations has allowed it to redirect resources toward high-growth areas. Cost-saving initiatives are projected to boost profits. 

ALL’s Protection Services unit’s revenues benefited from the solid performance of Allstate Protection Plans and Arity. We expect the Protection Services unit’s revenues to rise 12.9% YoY in 2025. ALL’s cash-generating abilities are crucial for returning capital to its shareholders. ALL repurchased shares worth $805 million in the first nine months of 2025.

The Allstate has an expected revenue and earnings growth rate of 5.7% and -14.5%, respectively, for next year. The Zacks Consensus Estimate for next year’s earnings has improved 0.1% over the last seven days.

Dillard's Inc.Dillard's is benefiting from its efforts to capture growth opportunities in brick-and-mortar stores and the e-commerce business, aiding in retaining existing customers and attracting new ones. DDS’ delivered steady growth in retail sales, with comps rising 1% year over year.

DDS is a leading player among fashion apparel, cosmetics and home furnishing retailers. The company offers a broad array of merchandise in its stores, featuring products from both national and exclusive brands. DDS’ strategy of providing fashion-forward and trendy products acts as a catalyst for attracting more customers.

Despite a challenging retail backdrop, DDS’ sales growth was supported by strength in juniors’, children’s apparel, ladies’ accessories, and lingerie. This reflects the company’s ability to drive category-specific momentum even as certain segments like home and furniture underperformed.

Dillard's has an expected revenue and earnings growth rate of 0.8% and -8.2%, respectively, for next year (ending January 2027). The Zacks Consensus Estimate for next year’s earnings has improved 3.6% over the last seven days.

Kinross Gold Corp.Kinross Gold has a strong production profile and boasts a promising pipeline of exploration and development projects. These projects are expected to boost production and cash flow and deliver significant value. KGC is focusing on organic growth through its Tasiast mine, where the Phase One expansion boosted production capacity, and the Tasiast 24K expansion further increased throughput and production. 

KGC’s Manh Choh project at Fort Knox is expected to extend operations and benefit from higher gold prices. The Great Bear project in Ontario also offers a promising long-term opportunity with substantial gold resources. Higher gold prices should also boost KGC’s profitability and drive cash flow generation.

Kinross Gold has an expected revenue and earnings growth rate of 6.3% and 32%, respectively, for next year. The Zacks Consensus Estimate for next year’s earnings has improved 7.9% over the last seven days.

Globus Medical Inc.Globus Medical’s Nevro acquisition is set to further solidify its position in the musculoskeletal space, with its differentiated technologies and expansion into new markets. Continued strength in the U.S. Spine business is encouraging. 

GMED’s NuVasive merger boosts its top line. Strong industry trends, driven by a rising aging population and musculoskeletal disorders, are expected to spur demand for GMED’s core products. Its debt-free balance sheet bodes well. GMED’s expanding product portfolio and a strong pipeline, looks promising.

Globus Medical has an expected revenue and earnings growth rate of 7.2% and 11.3%, respectively, for next year. The Zacks Consensus Estimate for next year’s earnings has improved 10.2% over the last 30 days.

An updated edition of the October 10, 2025 article.

3D Printing, widely known as additive manufacturing, has reshaped the way products are designed and produced. Introduced in the 1980s, the technology turns digital models into physical objects by building them layer by layer, offering unmatched precision, customization and efficiency.

What began as a prototyping technique has grown into a robust manufacturing solution used for everything from prosthetics and aerospace parts to architectural models and consumer goods. Unlike subtractive manufacturing, which carves a product from a block of material, additive manufacturing minimizes waste, enables greater customization and supports innovative, complex designs that traditional methods cannot achieve.

Businesses are now embracing 3D Printing for rapid prototyping and on-demand production, given its clear edge in terms of cost, customization, precision and sustainability compared with traditional manufacturing methods. While localized production can cut down supply chains and lower transportation costs, on-demand manufacturing eliminates the need to maintain large inventories. This is particularly beneficial for industries with seasonal demand or those requiring spare parts on an urgent basis. Leading players such as Xometry (XMTR - Free Report) , Proto Labs (PRLB - Free Report) and Stratasys (SSYS - Free Report) are spearheading innovation in this space.

Adoption is accelerating across healthcare, aerospace, automotive and consumer goods. In aerospace, it is used to manufacture lightweight, durable aircraft and spacecraft components. In the automotive industry, it is valuable for producing prototypes, tooling and even customized parts. The technology is transforming the medical field by producing personalized medical tools and generating prosthetic body parts for patients. It is pushing boundaries even further with advancements in tissue and organ printing, which could one day redefine modern medicine.

North America leads with more than 35% market share, supported by strong R&D investment, government initiatives and advanced manufacturing infrastructure. The Asia-Pacific region, led by China and India, is rapidly catching up, leveraging 3D Printing to boost its industrial competitiveness.

We believe that 3D Printing offers compelling growth opportunities for investors, supported by its expanding addressable market and strong innovation pipeline.

Our 3D Printing Screen makes it easy to identify high-potential stocks. Currently, stocks like Proto Labs, AMETEK (AME - Free Report) and ATI Inc. (ATI - Free Report) look lucrative. 

Ready to uncover more transformative thematic investment ideas? Explore 36 cutting-edge investment themes with Zacks Thematic Investing Screens and discover your next big opportunity.

3 Must-Have 3D Printing Stocks for Your PortfolioProto Labs is widely recognized as the world’s fastest digital manufacturing source for providing rapid prototypes and on-demand production parts. Backed by 25 years of additive manufacturing experience and more than 120 additive manufacturing machines, PRLB prints more than 250,000 parts each month and supports more than 50,000 product developers.

The company introduced its 3D Printing services in 2014 to streamline the shift from early prototyping to low-volume production. PRLB subsequently strengthened its 3D Printing capabilities by acquiring FineLine in 2014 and Alphaform in 2015. In September 2024, Proto Labs launched an advanced photopolymers technology, Axtra3D Hybrid PhotoSynthesis (HPS). It uses a precision laser and digital light processing system to simultaneously image internal and external part structures, overcoming traditional limitations.

Proto Labs currently provides an online 3D Printing service that enables customers to print their requirements into plastic, metal and elastomeric parts. It also offers several post-processing options to improve cosmetics or enhance mechanical properties. The company significantly expanded its U.S. manufacturing capacity in 2025 in response to the surging domestic demand for metal 3D-printed parts.

Recently, the company added four large-format, dual-laser Colibrium Additive M2 metal printers, increasing its capacity to produce complex, lightweight structures. This can help it cater to the medical device, aerospace, and defense industries. Protolabs also recently gained ISO 13485 certification for its DMLS production facility and AS9100D for aerospace manufacturing. PRLB sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.

AMETEK, through its Specialty Metal Products (SMP) division, is a leading producer of high-performance metal powders designed for additive manufacturing. It offers a range of alloys and size distributions specific to different additive manufacturing processes, including Laser Powder Bed, Binder Jet and Cold Spray and machines. AME’s most common additive manufacturing powder materials include stainless steel 316L (including A240 grade), Stainless steel 304L and Stainless steel 17-4PH. It also offers specialty austenitic and ferritic stainless steels, along with a selection of high-quality nickel and cobalt alloy powders that are designed specifically for 3D printing applications.

Backed by more than five decades of expertise, the combination of scale, precision and material science enables the company to deliver reliable, high-quality powders that support consistent performance and cost efficiency in additive manufacturing.

In July, AME closed the $920 million acquisition of Faro Technologies, a leading provider of 3D measurement and imaging solutions. Faro’s offerings include portable measurement arms, laser scanners and trackers, software solutions and comprehensive service offerings serving a diverse range of end markets. It is its largest addition in precision scanning since the acquisition of Creaform in 2013.  Creaform is a well-known developer and manufacturer of innovative portable 3D measurement technologies and a provider of 3D engineering services. In October 2024, the company had complemented Creaform’s business capabilities by acquiring Virtek Vision International, a leading provider of advanced laser-based projection and inspection systems. With Faro added to Creaform and Virtek under Ametek’s Ultra Precision Technologies division, the company now commands a solid 3D metrology portfolio. AME currently carries a Zacks Rank #2 (Buy). 

ATI offers a full range of capabilities throughout the additive supply chain, from metal powder and material science to the finished part. ATI Additive Manufacturing is one of the few providers to deliver expertise in both Electron Beam Melting and Direct Metal Laser Melting for additive parts.

Given its extensive powder metals offering, ATI Additive can quickly respond to customers' needs for their additive part demands. Leveraging ATI’s metallurgical leadership, it can also develop new alloys for additive manufacturing on request or address industry challenges.

The company continues to increase its production capacity for advanced metallic powders for use in next-generation aerospace products, including additive manufacturing applications. 

ATI has commissioned a state-of-the-art facility for additive manufacturing products, bringing online the most advanced large-format, metal additive manufacturing capabilities in the industry. The facility combines design, printing, heat treating, machining and inspection capabilities under one roof. From design to finished product, the company has created a one-stop solution center to address challenges in high-performance markets like aerospace, defense and space. ATI currently carries a Zacks Rank of 2.

On the whole, Big Tech accounts for almost half of the index's 2025 rise, according to DataTrek.

CHATSWORTH, Calif., Dec. 01, 2025 (GLOBE NEWSWIRE) -- XYRA Corp., a subsidiary of Cavitation Technologies, Inc. (OTCQB: CVAT), an AI-driven, quantum-secure payment network uniting remittances, fintech, and crypto assets under one tokenized, compliant infrastructure, today announced that it has secured a license agreement that will enable XYRA to accept and process digital assets in real time, such as USDC stablecoin, as well as leading cryptocurrencies like Bitcoin, Ethereum, and Tether, with instant conversion to U.S. dollars or local fiat currencies.

First Mile of XYRA’s Proprietary Ecosystem

Today’s remittance landscape is split between two different worlds, traditional banking and digital assets, each with its own limitations. Traditional banking is defined by delays and high fees, where settlement typically takes 2-5 days, and costs range from 6-8%. XYRA is developing proprietary infrastructure that enables instant settlements, global reach, and substantially lower fees for both small businesses and individual users.

The newly secured infrastructure will allow XYRA to:

Enable merchants to accept crypto or stablecoin seamlessly, without changing their existing workflow.Provide instant settlements in fiat, removing price volatility for businesses and users.Operate across borders, supporting transactions in multiple currencies and digital assets.Integrate directly into XYRA’s proprietary ecosystem. By deploying its proprietary platform, XYRA can bring core functionality online faster, while simultaneously expanding development of its full AI-driven, quantum-secure architecture.

“There’s a clear opportunity to finally bring remittance and fintech together,” said Anton Glotser, VP of Blockchain Infrastructure Technology at XYRA Corp. “From dollars and pesos to digital tokens, XYRA aims to make every transaction simple, fast, and secure.”

This agreement comes shortly after XYRA’s recently announced strategic partnership with Bitcoin Bancorp, Inc. (OTCQB: BCBC), which will integrate XYRA’s payment and security infrastructure into Bitcoin Bancorp’s licensed ATM network across North America.

Together, these steps strengthen XYRA’s early operational footprint while the company continues building its proprietary infrastructure.

About XYRA Corp.

XYRA Corp. is a Wyoming corporation and subsidiary of Cavitation Technologies, Inc., focused on identifying and capitalizing on opportunities in the crypto technologies market. The company holds an exclusive license for CTI's patented Cavitation Non-Thermal Plasma™ technology for submerged fluid cooling applications, positioning it to serve both cryptocurrency mining and data center immersion cooling markets. Under the leadership of Anton Glotser, VP of Blockchain Infrastructure Technology, XYRA Corp. is building a talented team of experts to identify unique technologies and opportunities in the rapidly evolving crypto and data center infrastructure sectors.

About Cavitation Technologies, Inc.

Founded in 2007, Cavitation Technologies, Inc. (OTCQB: CVAT), is a leading ESG company that designs and manufactures innovative flow-through nano-technology systems for fluid processing applications worldwide. The technology is designed for fluid processing across multiple industries: water treatment and remediation, agriculture, pharmaceuticals, oil & gas, edible oil refining, renewable fuels, alcoholic beverages enhancement, PFAS removal, and now, high-performance computing and digital asset infrastructure.

Our core products are Nano Reactor® systems, with scalable capacities ranging from 10 to 500 gallons per minute (GPM), and Cavitation Non-Thermal Plasma™ technology, which currently operates at 20 GPM and is scalable to a larger flow. These systems effectively eliminate bacteria and viruses, reduce TDS levels, lower turbidity, and offer the removal of PFAS in multiple water remediation applications.

CTi holds over 40 patents issued domestically and internationally.

Visit our website for more information:
https://www.cvatinfo.com/

Follow our social media for real-time updates:
Twitter: https://twitter.com/cvatinfo
LinkedIn: http://linkedin.com/company/cavitation-technologies
YouTube: https://www.youtube.com/@cvatinfo

Call or email us:
Cavitation Technologies, Inc.
818-718-0905
[email protected]

Forward-Looking Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by terminology such as ''may,'' ''should,'' ''potential,'' ''continue,'' ''expects,'' ''anticipates,'' ''intends,'' ''plans,'' ''believes,'' ''estimates,'' and similar expressions. These forward-looking statements are based largely on the Company's expectations and are subject to many risks and uncertainties, certain of which are beyond the Company's control. Actual results could differ materially from these forward-looking statements as a result of a variety of factors including, among others, our ability to install as anticipated, the state of the economy, the competitive environment and other factors described in our most recent Form 10-K and our other filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. In light of these risks and uncertainties, there can be no assurances that the forward-looking statements contained in this press release will transpire or prove to be accurate. The information in this release is provided only as of the release date, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

EFFINGHAM, Ill., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (Nasdaq: MSBI) today announced that its wholly owned subsidiary, Midland States Bank (“the Company”), has sold substantially all of its equipment finance portfolio to an affiliate of North Mill Equipment Finance LLC (“NMEF”). The transaction closed on November 28, 2025.

NMEF acquired the portfolio for $502 million in cash, subject to adjustment. As of October 31, 2025, the equipment finance portfolio consisted of approximately $599 million in loans and leases outstanding — or $565 million net of the allowance for credit losses — and $21 million of operating leases included in other assets. The transaction excludes approximately $75 million of loans and leases that will be retained by the Company, and as such, total loans and leases will be reduced by approximately $545 million as compared to October 31, 2025.

The Company expects to recognize a pre-tax loss on sale, including transaction-related expenses, of approximately $20 million in the fourth quarter of 2025.

The Company intends to use the majority of the proceeds from the sale to pay down approximately $350 million of high-cost wholesale funding.

The transaction aligns with the Company’s previously announced strategy to focus resources and capital on its core community banking operations and is expected to be accretive to capital and approximately neutral to earnings. As previously disclosed, the Company ceased originating new equipment finance loans and leases effective as of September 30, 2025.

Jeffrey G. Ludwig, President and Chief Executive Officer of Midland States Bancorp, Inc., stated:

“This transaction with NMEF represents a prudent step forward in sharpening our focus on community banking and wealth management. The sale of substantially all of the equipment finance portfolio follows other steps we’ve taken over the past year to improve our credit profile and enables us to redeploy capital more effectively. Altogether, these steps have strengthened our balance sheet, reduced our exposure to higher-risk asset classes, and helped position us well to continue growing the community bank into 2026.”

David C. Lee, Chairman & Chief Executive Officer of NMEF, stated:

“The strength of our long-standing banking, capital markets and equity capital relationships enabled us to execute with the speed and certainty required for this complicated transaction in a compressed timeframe. We’re pleased to welcome several Midland Equipment Finance employees into the NMEF family as we continue to scale our platform. As market volatility creates challenges for holders of non-core portfolios, NMEF remains a reliable partner for those seeking a thoughtful and efficient exit or financial partner.”

Stephens Inc. served as exclusive financial adviser to the Company in connection with the transaction. Barack Ferrazzano served as legal counsel to the Company. Moore & Van Allen PLLC served as legal counsel to NMEF.

About Midland States Bancorp, Inc.

Midland States Bancorp, Inc. is a community-based financial holding company headquartered in Effingham, Illinois, and is the sole shareholder of Midland States Bank. As of September 30, 2025, the Company had total assets of approximately $6.91 billion, and its Wealth Management Group had assets under administration of approximately $4.36 billion. The Company provides a full range of commercial and consumer banking products and services, merchant credit card services, trust and investment management, insurance and financial planning services. For additional information, visit midlandsb.com or follow Midland States Bank on LinkedIn.

About North Mill Equipment Finance LLC

North Mill Equipment Finance LLC is a national, premier lender that works primarily with third-party referral sources to finance small- to mid-ticket commercial equipment leases and loans. Headquartered in Norwalk, Connecticut, the Company serves businesses across a wide range of industries through a robust network of independent finance companies and brokers. NMEF delivers flexible, customized financing solutions to partners nationwide.

Forward-Looking Statements

Readers should note that in addition to the historical information contained herein, this press release includes “forward-looking statements” within the meanings of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including but not limited to statements about the Company’s expenses, use of proceeds, earnings, capital levels, plans, objectives, future performance and business strategy. These statements are subject to many risks and uncertainties, including uncertainties as to significant or unexpected costs, charges or expenses resulting from the transaction; the possibility that the parties may amend or modify certain terms of the transaction; changes in interest rates and other general economic, business and political conditions; the impact of federal trade policy, inflation, increased deposit volatility and potential regulatory developments; changes in the financial markets; changes in business plans as circumstances warrant; changes to U.S. tax laws, regulations and guidance; and other risks detailed from time to time in filings made by the Company with the Securities and Exchange Commission. Readers should note that the forward-looking statements included in this press release are not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “will,” “propose,” “may,” “plan,” “seek,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “continue,” or similar terminology. Any forward-looking statements presented herein are made only as of the date of this press release, and the Company does not undertake any obligation to update or revise any forward-looking statements to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.

CONTACTS:
Eric T. Lemke, Chief Financial Officer, at [email protected] or (217) 342-7321

Investor Presentation available: http://ml.globenewswire.com/Resource/Download/715f27cd-d5a3-4aba-93e5-87c7c92e1860

Management to Participate in 8th Annual Evercore Annual Healthcare Conference

December 01, 2025 09:00 ET

 | Source:

Mapi Pharma

NESS ZIONA, Israel, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on introducing innovative long-acting depot injectable treatments, will participate in the 8th Annual Evercore Annual Healthcare Conference, to take place December 2-4, 2025, in Miami, Florida.

Mapi is actively seeking additional partnerships for its new proprietary Depot products. Company management will be available for one-on-one meetings during the Annual Evercore Annual Healthcare Conference to discuss potential joint development collaborations. Interested parties should contact Mapi directly or their representative at Evercore to arrange a meeting.

Mapi utilizes extended-release Depot technologies with strong IP to develop Lifecycle Management products for innovative and existing commercially successful pharmaceuticals across multiple therapeutic areas. The Company currently has one product which is fully under a commercialization agreement, GA Depot for Relapsing Forms of Multiple Sclerosis (RMS) and other products for diabetes and schizophrenia which are funded through Phase II results.

The development pipeline also includes an injectable version of cariprazine, developed using Mapi’s Depot technology, which has demonstrated a long-acting release profile, for one monthly injection. It is designed to address an unmet need in the treatment of schizophrenia, bipolar I and major depression disorders. Mapi recently began enrolling patients in a Phase I/II study.

Mapi is fully integrated in the development of Depot pharmaceuticals and offers partners multiple distinct technologies. The Company has an extensive R&D team with dedicated Depot labs, experienced clinical team, as well as a large-scale, state-of-the-art GMP approved manufacturing facility for both clinical development and commercial supply. Mapi has the capabilities to efficiently develop Depot products by integrating R&D, clinical studies, registration and manufacturing with a successful track record of improving time to market.

Ehud Marom, Chairman and Chief Executive Officer, Mapi Pharma, said, “We have a number of compelling partnering opportunities in our current pipeline, including Deutetrabenazine (AUSTEDO® XR) Depot for the treatment of Huntington's disease and tardive dyskinesia, and Anastrazole (Arimidex®) Depot as an adjuvant treatment for postmenopausal women with hormone receptor-positive early breast cancer as well as other candidates. We can also apply our technologies to co-develop Depot drugs with companies that are interested in developing long-acting injectable lifecycle management versions of their molecules."

About Mapi Pharma
Mapi Pharma (Mapi) is a clinical stage pharmaceutical company, engaged in development of high barrier-to-entry and high added-value life cycle management ("LCM") products and AB Rated Depot injectable products that target large markets that include complex active pharmaceutical ingredients ("APIs") and formulations. Mapi’s lead product is GA Depot which is partnered with Viatris (NASDAQ: VTRS) in an agreement under which Viatris was granted an exclusive license to commercialize the GA Depot injection product for Relapsing Forms of Multiple Sclerosis (RMS). Following successful Phase 3 results GA Depot is currently under FDA review. The Company is also marketing its own generic versions of Fingolimod (Gilenya®) and Apremilast (Otezla®) in specific geographic markets. Mapi's portfolio also includes a leading development of Depot drugs for Schizophrenia, GLP-1 for diabetes, weight loss, with innovative intellectual property. Mapi is built on strong chemical and pharmaceutical R&D and clinical development capabilities and a deep understanding of the global market and of regulatory needs. Mapi is a global company with an API production and aseptic Depot manufacturing and a Fill & Finish for injectable Finished Dosage Forms facilities. Mapi has strong IP positions, filing numerous patent applications for APIs and formulations. For more information, please visit www.mapi-pharma.com

Contacts:
Alex Mogle
Vice President, Corporate Development
Mapi Pharma
+972 52 6080297
[email protected]

Brian Ritchie
Managing Director
LifeSci Advisors, LLC
[email protected]

December 01, 2025 09:00 ET

 | Source:

Arqit

LONDON, Dec. 01, 2025 (GLOBE NEWSWIRE) --

Arqit Quantum Inc. (“Arqit”), a leader in quantum safe encryption, announced it will report financial results for the fiscal year ending September 30, 2025 on Tuesday, December 9, 2025.

In conjunction with this announcement, Arqit will host a conference call at 11:00 a.m. ET / 8:00 a.m. PT on December 9, 2025 with the Company’s CEO, Andy Leaver, and CFO, Nick Pointon. A live webcast of the call will be available on the “News & Events” page of the Company’s website at ir.arqit.uk. To access the call by phone, please go to this link (registration link) and you will be provided with dial in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. A replay of the webcast will also be available for a limited time at ir.arqit.uk.

About Arqit 

Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW) supplies a unique encryption software service which makes the communications links of any networked device, cloud machine or data at rest secure against both current and future forms of attack on encryption – even from a quantum computer. Compatible with NSA CSfC Components and meeting the demands of NSA CSfC Symmetric Key Management Requirements Annexe 1.2. and RFC 8784, Arqit’s Symmetric Key Agreement Platform uses a lightweight software agent that allows end point devices to create encryption keys locally in partnership with any number of other devices. The keys are computationally secure and facilitate Zero Trust Network Access. It can create limitless volumes of keys with any group size and refresh rate and can regulate the secure entrance and exit of a device in a group. The agent is lightweight and will thus run on the smallest of end point devices. The product sits within a growing portfolio of granted patents. It also works in a standards compliant manner which does not oblige customers to make a disruptive rip and replace of their technology. In September 2024, Arqit was named as an IDC Innovator for Post-Quantum Cryptography, 2024. Arqit is winner of two GSMA Global Mobile Awards, The Best Mobile Security Solution and The CTO Choice Award for Outstanding Mobile Technology, at Mobile World Congress 2024, recognised for groundbreaking innovation at the 2023 Institution of Engineering and Technology Awards and winner of the National Cyber Awards’ Cyber Defence Product of the Year 2024 and Innovation in Cyber Award 2022, as well as the Cyber Security Awards’ Cyber Security Software Company of the Year Award 2022. Arqit is ISO 27001 Standard certified. www.arqitgroup.com

Media relations enquiries:

                Arqit: [email protected]

Investor relations enquiries:

                Arqit: [email protected]

Ali Mogharabi wasn't shocked to see the stark rally in Alphabet (GOOGL). Cloud growth is one factor he points to when characterizing the Mag 7 stock's stunning climb from April lows, with Gemini 3.0 adding to its software moat.

, /PRNewswire/ -- S&P Global (NYSE: SPGI) (the "Company" or "S&P Global") today announced that it is commencing an offering, subject to market conditions, of a tranche of senior notes due 2031 (the "2031 Notes") and a tranche of senior notes due 2035 (the "2035 Notes" and, together with the 2031 Notes, the "Notes") in a private placement transaction (the "Offering"). The Notes will be unsecured obligations of the Company and will be guaranteed by its subsidiary, Standard & Poor's Financial Services LLC.

The Company intends to use the net proceeds from the Offering for general corporate purposes, which may include, without limitation, funding of possible acquisitions, repayment, redemption or refinancing of indebtedness, capital expenditures, working capital, satisfaction of other obligations or repurchase of our outstanding common stock. We may temporarily invest the net proceeds of this offering in short-term, liquid investments until they are used for their stated purpose.

The Notes will be offered in the United States only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and outside the United States to non-U.S. persons pursuant to Regulation S under the Securities Act. The Notes have not been registered under the Securities Act and, unless so registered, may not be offered or sold in the United States absent an applicable exemption from registration requirements.

This press release does not constitute an offer to sell or the solicitation of an offer to buy the Notes, nor shall there be any sale of the Notes in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Any offer of the Notes will be made only by means of an offering memorandum.

About S&P Global

S&P Global (NYSE: SPGI) enables businesses, governments, and individuals with trusted data, expertise and technology to make decisions with conviction. We are Advancing Essential Intelligence through world-leading benchmarks, data, and insights that customers need in order to plan confidently, act decisively, and thrive economically in a rapidly changing global landscape.  

From helping our customers assess new investments across the capital and commodities markets to guiding them through the energy expansion, acceleration of artificial intelligence, and evolution of public and private markets, we enable the world's leading organizations to unlock opportunities, solve challenges, and plan for tomorrow – today.

Contact:

Investor Relations:
Mark Grant
Senior Vice President, Investor Relations and Treasurer
Tel: +1 (347) 640-1521
[email protected]

Media:
Christina Twomey
Chief Communications Officer
Tel: +1 (646) 407-3001
[email protected]

Forward-Looking Statements: 

This communication contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements, which are based on current expectations, estimates and projections about future business and operating results, the industry and markets in which the Company operates and beliefs of and assumptions made by the Company's management, involve uncertainties that could significantly affect the financial or operating results of the Company. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "will," "should," "may," "projects," "could," "would," "target," "estimates" or variations of such words and other similar expressions are intended to identify such forward-looking statements, which generally are not historical in nature, but not all forward-looking statements include such identifying words. For example, management may use forward-looking statements when addressing topics such as whether the Offering will be completed and the anticipated use of proceeds from the Offering. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in such forward-looking statements.

Forward-looking statements are subject to inherent risks and uncertainties. Factors that could cause actual results to differ materially from those expressed or implied in forward-looking statements include, among other things:

worldwide economic, financial, political, and regulatory conditions (including slower GDP growth or recession, restrictions on trade (e.g., tariffs), instability in the banking sector and inflation), and factors that contribute to uncertainty and volatility (e.g., supply chain risk), natural and man-made disasters, civil unrest, public health crises (e.g., pandemics), geopolitical uncertainty (including military conflict), and conditions that result from legislative, regulatory, trade and policy changes, including from the U.S. administration;
the volatility and health of debt, equity, commodities, energy and automotive markets, including credit quality and spreads, the composition and mix of credit maturity profiles, the level of liquidity and future debt issuances, equity flows from active to passive, fluctuations in average asset prices in global equities, demand for investment products that track indices and assessments and trading volumes of certain exchange-traded derivatives;
the demand and market for credit ratings in and across the sectors and geographies where the Company operates;
the Company's ability to maintain adequate physical, technical and administrative safeguards to protect the security of confidential information and data, and the potential for a system or network disruption that results in regulatory penalties and remedial costs or improper disclosure of confidential information or data;
the outcome of litigation, government and regulatory proceedings, investigations and inquiries;
concerns in the marketplace affecting the Company's credibility or otherwise affecting market perceptions of the integrity or utility of independent credit ratings, benchmarks, indices and other services;
the level of merger and acquisition activity in the United States and abroad;
the level of the Company's future cash flows and capital investments;
the effect of competitive products (including those incorporating generative artificial intelligence ("AI") and pricing, including the level of success of new product developments and global expansion;
the impact of customer cost-cutting pressures;
a decline in the demand for our products and services by our customers and other market participants;
our ability to develop new products or technologies, to integrate our products with new technologies (e.g., AI), or to compete with new products or technologies offered by new or existing competitors;
our ability to attract, incentivize and retain key employees, especially in a competitive business environment;
our ability to successfully navigate key organizational changes, including among our executive leadership;
the Company's exposure to potential criminal sanctions or civil penalties for noncompliance with foreign and U.S. laws and regulations that are applicable in the jurisdictions in which it operates, including sanctions laws relating to countries such as Iran, Russia and Venezuela, anti-corruption laws such as the U.S. Foreign Corrupt Practices Act and the U.K. Bribery Act of 2010, and local laws prohibiting corrupt payments to government officials, as well as import and export restrictions;
the continuously evolving regulatory environment in Europe, the United States and elsewhere around the globe affecting each of our businesses and the products they offer, and our compliance therewith;
the Company's ability to make acquisitions and dispositions and successfully integrate the businesses we acquire;
consolidation of the Company's customers, suppliers or competitors;
the introduction of competing products or technologies by other companies;
the ability of the Company, and its third-party service providers, to maintain adequate physical and technological infrastructure;
the Company's ability to successfully recover from a disaster or other business continuity problem, such as an earthquake, hurricane, flood, civil unrest, protests, military conflict, terrorist attack, outbreak of pandemic or contagious diseases, security breach, cyber attack, data breach, power loss, telecommunications failure or other natural or man-made event;
the impact on the Company's revenue and net income caused by fluctuations in foreign currency exchange rates;
the impact of changes in applicable tax or accounting requirements on the Company;
the separation of S&P Global Mobility ("Mobility") into a standalone public company not being consummated within the anticipated time period or at all;
the ability of the separation of Mobility to qualify for tax-free treatment for U.S. federal income tax purposes;
any disruption to the Company's business in connection with the proposed separation of Mobility;
any loss of synergies from separating the businesses of Mobility and the Company that adversely impact the results of operations of both businesses, or the companies resulting from the separation of Mobility not realizing all of the expected benefits of the separation;
following the separation of Mobility, the combined value of the common stock of the two publicly-traded companies not being equal to or greater than the value of the Company's common stock had the separation not occurred; and
the outcome of the Offering.

The factors noted above are not exhaustive. The Company and its subsidiaries operate in a dynamic business environment in which new risks emerge frequently. Accordingly, the Company cautions readers not to place undue reliance on any forward-looking statements, which speak only as of the dates on which they are made. The Company undertakes no obligation to update or revise any forward-looking statement to reflect events or circumstances arising after the date on which it is made, except as required by applicable law. Further information about the Company's businesses, including information about factors that could materially affect its results of operations and financial condition, is contained in the Company's filings with the SEC, including Item 1A, Risk Factors in our most recently filed Annual Report on Form 10-K, as supplemented by Item 1A, Risk Factors, in our most recently filed Quarterly Report on Form 10-Q.

SOURCE S&P Global

AI-driven shopping tools boosted U.S. online spending this Black Friday, as consumers avoided stores and used chatbots to compare prices and lock in deals amid tariff concerns. The holiday season this year started amid tighter budgets, and rising unemployment (which is hovering around a four-year high).

Still, U.S. shoppers spent a record $11.8 billion online, up 9.1% from 2024, according to Adobe Analytics, which tracks 1 trillion website visits, per Reuters, as quoted on Yahoo Finance.

E-Commerce Growth Outpaces In-Store SalesOnline demand jumped sharply, with e-commerce sales rising 10.4% compared with just 1.7% in-store growth, Mastercard SpendingPulse reported, as quoted on the above-mentioned source.  AI-driven traffic to U.S. retail websites surged 805% from last year, per Adobe, as quoted on the above-mentioned source.

Popular Black Friday purchases included the likes of LEGO sets, Pokémon cards, Nintendo Switch and PS5 consoles, and items like Apple AirPods.

AI Agents Drive $14.2 Billion in Global SalesGlobally, AI agents drove $14.2 billion in online Black Friday sales, with $3 billion coming from the United States, according to Salesforce, as mentioned in the same Yahoo Finance article. Salesforce data — covering both discretionary and non-discretionary purchases — revealed that U.S. consumers shelled out $18 billion online, up 3% year over year.

Cyber Monday Likely to Break RecordsThe spending momentum is expected to continue into Cyber Monday, with Adobe projecting $14.2 billion in sales, up 6.3% year over year and on track to become the largest online shopping day of 2025, as quoted on the above-mentioned source.

Any Wall of Worry?Despite higher spending, shoppers bought fewer items per order as rising prices weighed on demand. Discount levels remained flat from 2024, and higher product costs limited retailers’ ability to offer steeper promotions. Many shoppers expressed caution about overspending amid ongoing inflation, tariff uncertainty, and a soft labor market.

Artificial Intelligence ETFs in Focus  Against this backdrop, below we highlight a few AI-based exchange-traded funds (ETFs) that could be tapped now. These ETFs include iShares U.S. Technology ETF (IYW - Free Report) , Global X Artificial Intelligence & Technology ETF (AIQ - Free Report) , First Trust Dow Jones Internet Index Fund (FDN - Free Report) , iShares Future Exponential Technologies ETF (XT - Free Report) and Global X Robotics & Artificial Intelligence ETF (BOTZ - Free Report) .

Key Takeaways TILE is highlighted for cash flow at or above its five-year average and a higher 2025 earnings estimate.GLDD meets the rising cash-flow screen and has seen its 2025 earnings estimate move up this month.NRIM qualifies as improving cash flow aligns with an upgraded current-year earnings forecast.
Profit remains an essential objective for any business, yet steady cash flow is what truly sustains operations and long-term growth. Even profitable companies can stumble or face bankruptcy if they lack sufficient liquidity to meet day-to-day obligations. In contrast, firms with strong cash reserves are better equipped to navigate market volatility and unexpected disruptions, using available funds as a buffer against financial stress.

In this regard, stocks like Interface, Inc. (TILE - Free Report) , Great Lakes Dredge & Dock Corporation (GLDD - Free Report) , Northrim BanCorp, Inc. (NRIM - Free Report) and Strattec Security Corporation (STRT - Free Report) are worth buying.

A healthy cash position indicates that profits are being efficiently channeled to the company’s reserves. This offers flexibility to make decisions, chase potential investments and fuel its growth engine. It is indeed an accurate indicator of a company’s financial health and a measure of resiliency.

Analyzing a company’s cash-generating efficiency has indeed become more relevant amid uncertainties in the global economy, market disruptions and dislocations, as well as liquidity concerns.

To figure out this efficiency, one needs to consider a company’s net cash flow. While in any business, cash moves in and out, it is net cash flow that explains how much money a company is actually generating.

If a company is experiencing a positive cash flow, it denotes an increase in its liquid assets, which gives it the means to meet debt obligations, shell out for expenses, reinvest in the business, endure downturns and finally return wealth to shareholders. On the other hand, a negative cash flow indicates a decline in the company’s liquidity, which in turn lowers its flexibility to support these moves.

However, having a positive cash flow merely does not secure a company’s future growth. To ride on the growth curve, a company must have its cash flow increasing because that indicates management’s efficiency in regulating its cash movements and less dependency on outside financing for running its business.

Therefore, keep yourself abreast with the following screen to bet on stocks with rising cash flows.

Screening Parameters:To find stocks that have seen increasing cash flow over time, we ran the screen for those whose cash flow in the latest reported quarter was at least equal to or greater than the 5-year average cash flow per common share. This implies a positive trend and increasing cash over a period of time.

In addition to this, we chose:

Zacks Rank 1: No matter whether market conditions are good or bad, stocks with a Zacks Rank #1 (Strong Buy) have a proven history of outperformance. You can see the complete list of today’s Zacks #1 Rank stocks here.

Average Broker Rating 1: This indicates that brokers are also highly hopeful about the company’s future performance.

Current Price greater than or equal to $5: This sieves out low-priced stocks.

VGM Score of B or better: This score is also of great assistance in selecting stocks. Importantly, this scoring system helps in picking winning stocks in their industry categories.

Here are four out of eight stocks that qualified the screening:

Interface is a global flooring solution provider, delivering a range of carpet tile and resilient flooring, which it markets under the Interface and FLOR brands, for both commercial and residential environments.

The Zacks Consensus Estimate for Interface’s 2025 earnings has been revised upward 8.8% to $1.85 per share in the past month. TILE has a VGM Score of A.

Great Lakes Dredge & Dock is the largest provider of dredging services in the United States, conducting business to maintain and deepen shipping channels, reclaim land from the ocean and renourish storm-damaged coastline.

The Zacks Consensus Estimate for Great Lakes Dredge & Dock’s 2025 earnings has moved upward by 7.8% to $1.10 per share over the past month. GLDD has a VGM Score of A.

Northrim BanCorp is a full-service commercial bank that provides a full range of personal and business banking services. It is the parent company of Northrim Bank, an Alaska-based community bank, leveraging deep local expertise and strong customer-first service across the state.

The Zacks Consensus Estimate for Northrim BanCorp’s current-year earnings has improved 6.4% over the past month to $2.50. NRIM has a VGM Score of A.

Strattec Security provides smart vehicle access, security and authorization solutions for the global automotive industry. Its portfolio spans power access components, latches, start systems, keys, fobs, locksets, door handles and related products, supporting functions such as powered liftgates, sliding doors and tailgate operations.

The Zacks Consensus Estimate for Strattec Security’s fiscal 2026 earnings has risen 23.3% over the past month to $5.24. STRT has a VGM Score of A.

Get the rest of the stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and back-testing software.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.

December 01, 2025 9:03 AM EST | Source: PTX Metals Inc.
Toronto, Ontario--(Newsfile Corp. - December 1, 2025) - PTX Metals Inc. (TSXV: PTX) (OTCQB: PANXF) (FSE: 9PX) ("PTX" or the "Company") is pleased to announce commencement of a 5,000m diamond drilling program at its W2 Copper-Nickel and Platinum-Palladium-Gold (PGE) Project in Ontario, Canada. Drilling is focused on the Central Target with the initial holes targeting the CA1 and AP zones. 

The objectives of the first phase of the program are to test and delineate known exploratory targets (see press release dated September 4th, 2024) with the goal of enhancing the resource estimate, as well as expand the identified mineralized bodies with step-out holes within geologically prospective zones. Through the first phase of drilling, the Company is also targeting and building it's understanding of the higher-grade zones and possible enrichment within a larger sulfide-bearing envelop previously identified, along with testing geophysical targets.

Drill planning was based on multiple lines of geological evidence, leading to targeting of a never-before-tested geological interpretation of the property which is expected to more precisely guide current and future drilling at the W2 property. Data considered during drill planning includes, but is not limited to, previous PTX and historic drilling cumulating more than a 120 drill holes, the recent 2025 high-resolution magnetic survey and the subsequent 3D inversion model, the electromagnetic survey and the resulting Maxwell Plates. Latest compilation of data and the newest drill holes from PTX show that the mineralization is mainly hosted within a deformed, sulfide-bearing, highly magnetic gabbroic unit, which has been affected by various structural regimes. These previous steps allow significant de-risking for targeting wide mineralized intersections and potential localized massive sulfides zones intercepts.

The current work is being conducted and based out of an exploration camp at the property located 60km south of Webequie First Nation (WFN), where various support services at WFN are being used for the W2 Project.

Greg Ferron, CEO & President states: "We are particularly excited to be back drilling at the W2 Project this year with a more extensive program. We have taken significant steps for the Project and for the Company to improve our geological understanding of the deposit, that we are now ready to further test and build on the large exploration target issued in 2024. We are also pleased to be partnering with several professional service providers at W2 including Cyr Drilling, SGS, Haveman, Wisk Air, Webequie First Nations and our internal team. Importantly, with three recent infrastructure announcements in the immediate region including two landmark First Nations agreements with Ontario government, positive progress with metallurgy work and a strong commodity environment, W2 is very well positioned today."

Currently progressing additional activities at the W2 Project:

The Company continues to advance the project increasing knowledge with the preliminary metallurgical results received, highly anticipated impending age dating, paragenesis study, resource modeling and geological 3D interpretations still pending for results.

Additionally, a high-resolution topography and orthophoto LIDAR survey was flown by KBM Resources Group and completed on October 25th for the Central Target.

Qualified PersonThe technical information presented in this news release has been reviewed and approved by Kyle Pedersen, a non-independent qualified person to PTX Metals who is responsible for ensuring that the related technical information provided in this news release is accurate and who act as a "qualified person" (QP) as defined by National Instrument 43-101, Standards of Disclosure for Mineral Projects.

About PTX Metals IncPTX is a mineral exploration company focused on high-quality strategic metals assets in northern Ontario, allowing exposure for shareholders to Copper, Gold, Nickel, and PGEs discoveries. The Province of Ontario is a renowned mining jurisdiction for its abundance of mineral resources and safe jurisdiction.

Our corporate objective is to advance our assets, and unveil the potential of two Flagship Projects, the W2 Cu-Ni-PGE located in the strategic Ring of Fire region, and the Shining Tree Gold Project neighbor to other known deposits in the Timmins Gold Camp.

PTX's portfolio of assets was strategically acquired for their geologically favorable attributes, and proximity to established mining companies.

PTX is based in Toronto, Canada, with a primary listing on the TSX under the symbol PTX. The Company is also listed in Frankfurt under the symbol 9PF and on the OTCQB in the United States as PANXF.

For additional information on PTX, please visit the Company's website at https://ptxmetals.com/.

Forward-Looking InformationThis news release contains forward-looking information which is not comprised of historical facts. Forward-looking information is characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, and opportunities to differ materially from those expressed or implied by such forward-looking information, including statements regarding the ability of the Company to satisfy the regulatory, stock exchange and commercial closing conditions of Private Placement, and the potential development of mineral resources and mineral reserves which may or may not occur. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, changes in the state of equity and debt markets, fluctuations in commodity prices, delays in obtaining required regulatory or governmental approvals, and general economic and political conditions. Forward looking information in this news release is based on the opinions and assumptions of management considered reasonable as of the date hereof, including that all necessary approvals, including governmental and regulatory approvals, will be received as and when expected. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether because of new information, future events or otherwise, other than as required by applicable laws. For more information on the risks, uncertainties and assumptions that could cause our actual results to differ from current expectations, please refer to the Company's public filings available under the Company's profile at www.sedarplus.ca.

This news release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of any of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful, including any of the securities in the United States of America. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the "1933 Act") or any state securities laws and may not be offered or sold within the United States or to, or for account or benefit of, U.S. Persons (as defined in Regulation S under the 1933 Act) unless registered under the 1933 Act and applicable state securities laws, or an exemption from such registration requirements is available.

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276431

Meta Platforms (NASDAQ:META ) has been on a terrific run since it bottomed out in late 2022.

Bed Bath & Beyond should acquire The Brand Collective in 2026, shuttering 40 stores. (Photo by Joe Raedle/Getty Images)

Getty Images

In a move that signals a further reshaping of the home goods retail landscape, Bed Bath & Beyond Inc. has agreed to acquire The Brand House Collective in a deal valued at roughly $26.8 million.

The all-stock transaction means shareholders of The Brand House Collective will receive 0.1993 shares of Bed Bath & Beyond common stock for each share they own and the deal will formalize a relationship that has been evolving over the past year.

Roughly 40% of The Brand House Collective’s shares were already held by Bed Bath & Beyond, easing the path to consolidation.

The strategic narrative is to reposition Bed Bath & Beyond as an everything for the home retailer, combining the legacy value of its brand with the operational agility and store discipline of The Brand House Collective, the company said. As part of the deal, the company expects to cut more than $20 million in duplicated costs, including shuttering 40 stores next year.

The chain, once a U.S. retail juggernaut in housewares and bedding, filed for Chapter 11 bankruptcy in April 2023, ultimately liquidating all remaining stores. In the months following, the brand name and intellectual property were acquired by online retailer Overstock.com via bankruptcy auction and it quickly rebranded under Bed Bath & Beyond. The revived BBBY and has been quietly rebuilding its empire.

Bed Bath & Beyond ReshapesThe partnership with The Brand House Collective began in late 2024, when Garnland’s Home stores began being repurposed and rebranded as Bed Bath & Beyond Home outlets. That paved the way for the full acquisition after the companies saw early conversions deliver double-digit sales growth.

As the acquisition closes, anticipated in the first quarter of 2026 pending shareholder approval and lender consent, the newly formed retail group will be overseen by The Brand House Collective’s current CEO, Amy Sullivan, who will head up the new Beyond Retail Group.

Her remit will span merchandising, store operations, digital commerce and customer experience across Bed Bath & Beyond and its sibling brands including buybuy BABY, brand-house home décor and the banner once rolled out under Kirkland’s Home.

Bath & Body Works New FocusMeanwhile Bath & Body Works Inc., the personal-care and home-fragrance specialist, has announced a transformation plan under its new CEO, Daniel Heaf — a former executive at sports apparel giant Nike — dubbed the ‘Consumer First Formula’. The strategy is seeking to realign the brand with its core strengths in body care, home fragrances, soaps and sanitizers.

Bath & Body Works is pledging to refocus on its core ranges. (Photo by Justin Sullivan/Getty Images)

Getty Images

The urgency stems from a third quarter that fell short of expectations. Net sales slid 1% year-on-year to $1.59 billion, while net income dropped sharply, with a decline of more than 27%. Forecasts now show Q4 revenues likely to dip by high single digits, well below earlier projections of modest growth.

Bath & Body Works had expanded aggressively into new categories such as hair care and men’s grooming, yet the core body-care and fragrance lines were neglected. Heaf described the business he inherited as “slow and inefficient" and hampered by “unnecessary complexity”.

To steer the company back on course, the new focus will emphasize a simplified product assortment, a sharper focus on trend innovation, ingredient-led formulations and elevated brand storytelling.

At the same time, the company plans to leverage new channels, notably launching on Amazon, using interactive kiosks, pop-ups and physical experiences to reach younger consumers. However, it has a steep mountain to climb, with its stock value down by over 50% in the year-to-date, despite a small rally since the announcement.

The stories of Bed Bath & Beyond and Bath & Body Works share a broader theme, as legacy brand names scramble to reinvent themselves amid shifting consumer behavior, tightening wallets and a persistently challenging retail environment.

For Bed Bath & Beyond, the challenge is building back credibility and scale, while avoiding the baggage of its pre-2023 collapse, while for Bath & Body Works it is about rediscovering the essence that made it successful.

Key Takeaways LTH, CAH, LMAT and FLS boast high interest coverage ratios, signaling stronger debt-servicing ability.Each stock shows projected EPS and sales growth for the current financial year.All four companies have a Zacks Rank #2 and VGM Scores of A or B, reinforcing their financial strength.
An ill-informed investor can easily lose money by betting on a stock solely based on the numbers flashing across a real-time screen. As we move toward 2026, this risk becomes even more pronounced, with the market navigating inflationary pressures, shifting rate expectations, geopolitical uncertainties and uneven sectoral growth. Against such a backdrop, a deeper evaluation of a company’s financials is essential to make informed investment decisions.

Too often, investors gauge a company’s performance by looking only at headline sales or earnings. What these numbers don’t reveal is whether a company’s fundamentals are strong enough to meet its financial obligations in a tighter, more rate-sensitive environment. That’s where coverage ratios become invaluable. A higher coverage ratio signals a stronger capacity to service debt and sustain operations, making it a critical indicator of financial stability for investors seeking safer opportunities heading into 2026.

Life Time Group Holdings, Inc. (LTH - Free Report) , Cardinal Health, Inc. (CAH - Free Report) , LeMaitre Vascular, Inc. (LMAT - Free Report) and Flowserve Corporation (FLS - Free Report) have impressive interest coverage ratios.

Why Interest Coverage Ratio?The interest coverage ratio is used to determine how effectively a company can pay interest charges on its debt.

Debt, which is crucial to financing operations for the majority of companies, comes at a cost called interest. Interest expense has a direct bearing on the profitability of a company. The company’s creditworthiness depends on how effectively it meets its interest obligations. Therefore, the interest coverage ratio is one of the important criteria to factor in before making any investment decision.

Interest Coverage Ratio = Earnings before Interest & Taxes (EBIT) divided by Interest Expense.

The interest coverage ratio suggests how many times the interest could be paid from earnings and gauges the margin of safety a firm has for paying interest.

An interest coverage ratio lower than 1 suggests that the company is unable to fulfill its interest obligations and could default on repaying debt. A company capable of generating earnings well above its interest expense can withstand financial hardships. One should also track the company’s past performance to determine whether the interest coverage ratio has improved or worsened over time.

The Winning StrategyApart from having an interest coverage ratio that is more than the industry average, adding a favorable Zacks Rank and a VGM Score of A or B to your search criteria should lead to better results.

Interest coverage ratio greater than X-Industry Median

Price greater than or equal to 5: The stocks must all be trading at a minimum of $5 or higher.

5-Year Historical EPS Growth (%) greater than X-Industry Median: Stocks with a strong EPS growth history.

Projected EPS Growth (%) greater than X-Industry Median: This is the projected EPS growth over the next three to five years. This shows that the stock has near-term earnings growth potential.

Average 20-Day Volume greater than 100,000: A substantial trading volume ensures that the stock is easily tradable.

Zacks Rank less than or equal to 2: Zacks Rank #1 (Strong Buy) or 2 (Buy) stocks are known to outperform irrespective of the market environment.

VGM Score of less than or equal to B: Our research shows that stocks with a VGM Score of A or B, when combined with a Zacks Rank #1 or 2, offer the best upside potential.

Here are four of the 11 stocks that qualified the screening:

Life Time Group, the nation's premier healthy lifestyle brand, carries a Zacks Rank #2. The company has a trailing four-quarter earnings surprise of 22.4%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for Life Time Group’s current financial-year sales and EPS implies growth of 13.8% and 57.9%, respectively, from the year-ago period. Life Time Group has a VGM Score of A. Shares of Life Time Group have risen 16.5% in the past year.

Cardinal Health, a global healthcare company that distributes pharmaceuticals, manufactures and supplies medical and laboratory products, carries a Zacks Rank #2 and has a VGM Score of A. CAH has a trailing four-quarter earnings surprise of 9.4%, on average.

The Zacks Consensus Estimate for Cardinal Health’s current financial-year sales and EPS indicates growth of 16.2% and 19.7%, respectively, from the year-ago period. The stock has soared 73.3% in the past year.

LeMaitre Vascular, a provider of vascular devices, implants, and services, carries a Zacks Rank #2 and has a VGM Score of B. The company has a trailing four-quarter earnings surprise of 2.5%, on average.

The Zacks Consensus Estimate for LeMaitre Vascular’s current financial-year sales and EPS calls for growth of 12.9% and 30.1%, respectively, from the year-ago period. The stock has declined 21.3% in the past year.

Flowserve, a leading provider of flow control products and services for the global infrastructure markets, carries a Zacks Rank #2 and has a VGM Score of B. The company has a trailing four-quarter earnings surprise of 10.5%, on average.

The Zacks Consensus Estimate for Flowserve’s current financial-year sales and EPS suggests growth of 4.6% and 31.9%, respectively, from the year-ago period. The stock has advanced 17.2% in the past year.

You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and backtest them first before taking the investment plunge.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.Disclosure: Performance information for Zacks’ portfolios and strategies is available at: https://www.zacks.com/performance.

LOS ANGELES, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The DJS Law Group reminds investors of a class action lawsuit against Alexandria Real Estate Equities, Inc. (“Alexandria” or “the Company”) (NYSE: ARE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of ARE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: January 27, 2025 to October 27, 2025

DEADLINE: January 26, 2026

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Alexandria falsely claimed its positive comments about topics including its development tenant pipeline were based in fact. Based on these facts, Alexandria’s public statements were false and materially misleading throughout the class period.

If you are a shareholder who suffered a loss, contact us to participate.

NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. There is no cost or obligation to you to participate in this case.

WHY DJS LAW GROUP? DJS Law Group’s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

Join the case to recover your losses.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

David J. Schwartz

DJS Law Group

274 White Plains Road, Suite 1

Eastchester, NY 10709

Phone: 914-206-9742

Email: [email protected]

December 01, 2025 8:00 AM EST | Source: Burcon NutraScience Corporation
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in plant-based protein innovation, is pleased to announce that the Company insiders ("Insiders") have increased their commitment to participating in the previously announced non-brokered private placement (the "Offering") (see news release of the Company dated November 12, 2025) of convertible debentures (the "Convertible Debentures").

"Burcon insiders and its largest shareholders have once again shown confidence in our business plan and sales trajectory by expanding their investment," said Kip Underwood, Burcon's chief executive officer. "Their continued support underscores the commercial momentum we carry into 2026 and reinforces our ability to execute and deliver value for shareholders."

Burcon previously announced insider participation at a minimum of $2.0 million in principal amount. Since November 12, 2025, Burcon has received strong interest from potential investors in the Offering including increased interest from Insiders. Burcon anticipates the increased insider participation in the Offering could necessitate disinterested shareholder approval.

The Offering was expected to close on or about November 28, 2025. Given the increased interest in the Offering and the timing required to obtain shareholder approval, the timeline for closing the Offering will be extended. The Company is working with its key investors to finalize the terms and conditions of the Offering, which may change from what was previously announced. The Offering is subject to execution of subscription agreements by the placees and to certain conditions including, but not limited to, the receipt of all necessary regulatory approvals, including the approval of the TSX and disinterested shareholders.

About Burcon NutraScience Corporation

Burcon is a global technology leader in high-performance plant-based proteins for the food and beverage industry. Our commercial ingredients offer superior taste, texture, and functionality—ideal for formulators seeking next-generation protein solutions. Backed by over two decades of innovation, Burcon holds an extensive patent portfolio covering novel proteins derived from pea, canola, soy, hemp, sunflower, and other plant sources. As a key player in the rapidly growing plant-based market, Burcon is committed to sustainability and to creating best-in-class protein solutions that are better for people and the planet. Learn more at www.burcon.ca.

Forward-Looking Information Cautionary Statement
The TSX has not reviewed and does not accept responsibility for the adequacy of the content of the information contained herein. This press release contains forward-looking statements or forward-looking information within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation, including statements relating to insider participation in the private placement. Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements. Forward-looking statements or forward-looking information can be identified by words such as "anticipate," "aim", "intend," "plan," "goal," "project," "estimate," "expect," "believe," "future," "likely," "may," "should," "could," "will" and similar references to future periods. All statements included in this release, other than statements of historical fact, are forward-looking statements. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements or information. Important factors that could cause actual results to differ materially from Burcon's plans and expectations include the implementation of our business model and growth strategies; trends and competition in our industry our future business development, financial condition and results of operations and our ability to obtain financing cost-effectively; potential changes of government regulations, and other risks and factors detailed herein and from time to time in the filings made by Burcon with securities regulators and stock exchanges, including in the section entitled "Risk Factors" in Burcon's annual information form for the year ended March 31, 2025 and its other public filings with Canadian securities regulators on SEDAR+ at www.sedarplus.ca. This list is not exhaustive of the factors that may affect any of the Company's forward-looking statements or information. Any forward-looking statement or information speaks only as of the date on which it was made, and, except as may be required by applicable securities laws, Burcon disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. Although Burcon believes the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and, accordingly, investors should not rely on such statements.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276404

STMicroelectronics announces status
of common share repurchase program

Disclosure of Transactions in Own Shares – Period from November 24, 2025 to November 25, 2025

AMSTERDAM – December 01, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global semiconductor leader serving customers across the spectrum of electronics applications, announces full details of its common share repurchase program (the “Program”) disclosed via a press release dated June 21, 2024. The Program was approved by a shareholder resolution dated May 22, 2024 and by the supervisory board.

STMicroelectronics N.V. (registered with the trade register under number 33194537) (LEI: 213800Z8NOHIKRI42W10) announces the repurchase (by a broker acting for the Company) on the regulated market of Euronext Paris, in the period between November 21, 2025 to November 25, 2025 (the “Period”), of 206,478 ordinary shares (equal to 0.02% of its issued share capital) at the weighted average purchase price per share of EUR 19.1345 and for an overall price of EUR    3,950,859.05.

The purpose of these transactions under article 5(2) of Regulation (EU) 596/2014 (the Market Abuse Regulation) was to meet obligations arising from share option programmes, or other allocations of shares, to employees or to members of the administrative, management or supervisory bodies of the issuer or of an associate company.

The shares may be held in treasury prior to being used for such purpose and, to the extent that they are not ultimately needed for such purpose, they may be used for any other lawful purpose under article 5(2) of the Market Abuse Regulation.

Below is a summary of the repurchase transactions made in the course of the Period in relation to the ordinary shares of STMicroelectronics (ISIN: NL0000226223), in detailed form.

 Transactions in Period

Dates of transactionNumber of shares purchasedWeighted average purchase price per share (EUR)Total amount paid (EUR)Market on which the shares were bought (MIC code)24-Nov-25 121,609 19.1007 2,322,817.03 XPAR25-Nov-25 84,869 19.1830 1,628,042.03 XPARTotal for Period206,478 19.1345 3,950,859.05   Following the share buybacks detailed above, the Company holds in total 22,535,661 treasury shares, which represents approximately 2.5% of the Company’s issued share capital.

In accordance with Article 5(1)(b) of the Market Abuse Regulation and Article 2(3) of Commission Delegated Regulation (EU) 2016/1052, a full breakdown of the individual trades in the Program are disclosed on the ST website (https://investors.st.com/stock-and-bond-information/share-buyback).

About STMicroelectronics
At ST, we are 50,000 creators and makers of semiconductor technologies mastering the semiconductor supply chain with state-of-the-art manufacturing facilities. An integrated device manufacturer, we work with more than 200,000 customers and thousands of partners to design and build products, solutions, and ecosystems that address their challenges and opportunities, and the need to support a more sustainable world. Our technologies enable smarter mobility, more efficient power and energy management, and the wide-scale deployment of cloud-connected autonomous things. We are on track to be carbon neutral in all direct and indirect emissions (scopes 1 and 2), product transportation, business travel, and employee commuting emissions (our scope 3 focus), and to achieve our 100% renewable electricity sourcing goal by the end of 2027. Further information can be found at www.st.com.

For further information, please contact:

INVESTOR RELATIONS:
Jérôme Ramel
EVP Corporate Development & Integrated External Communication
Tel: +41.22.929.59.20
[email protected]

MEDIA RELATIONS:
Alexis Breton        
Corporate External Communications
Tel: +33.6.59.16.79.08
[email protected]

C3375C -- Dec 1 2025 -- Disclosure of transactions in Own Shares PR_FINAL FOR PUBLICATION

Analyst’s Disclosure:I/we have a beneficial long position in the shares of HROW either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

SummaryRoyal Gold is rated a buy, supported by a capital-light, high-margin business model and a robust dividend growth track record.The company's recent acquisitions, efficient operations, and balanced asset portfolio position it for strong cash flow and double-digit growth through 2027.Despite a 40% rally in 2025, RGLD trades at a 32% discount to fair value, offering 53% upside potential and 18%+ annual total returns.The dividend is well-covered, with a 25-year growth streak and low payout ratios, supporting further increases and sector-leading dividend consistency.Black Friday Sale 2025: Get 20% Offe-crow/iStock via Getty Images

Co-authored with Kody's Dividends

Seeking Alpha is constantly attracting new readers to the platform. At the risk of sounding like a broken record to longtime readers, I think it would be worthwhile for me to once again highlight

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Kody is long V and RGLD

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the Trump administration to make the medicine more accessible.

The announcement also comes weeks after chief rival Novo Nordisk unveiled additional discounts on the cash prices of its obesity and diabetes drugs. 

Starting Monday, cash-paying patients with a valid prescription can get the starting dose of Zepbound vials for as low as $299 per month on LillyDirect, down from a previous price of $349 per month. They can also access the next dose – 5 milligrams – for $399 per month and all other doses for $449 per month, down from $499 per month across those sizes. 

Zepbound carries a list price of roughly $1,086 per month. That price point, and spotty insurance coverage for weight loss drugs in the U.S., have been significant barriers to access for some patients. 

Eli Lilly's announcement comes just weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs easier for Americans to get and afford. The agreements will cut the prices the government pays for the drugs, introduce Medicare coverage of obesity drugs for the first time for certain patients and offer discounted medicines on the government's new direct-to-consumer website launching in January, TrumpRx. 

But Eli Lilly's deal with Trump centers around lowering the prices of a different form of Zepbound – a multi-dose pen – after it wins Food and Drug Administration approval. 

That means Eli Lilly's Monday announcement around cutting prices on the existing single-dose vials could allow more patients to get discounted treatments more quickly. 

"We will keep working to provide more options – expanding choices for delivery devices and creating new pathways for access – so more people can get the medicines they need," said Ilya Yuffa, president of Lilly USA and global customer capabilities, in a statement. 

With single-dose vials, patients need to use a syringe and needle to draw up the medicine and inject themselves. Eli Lilly first introduced that form of Zepbound in August 2024. 

It's unclear how many patients are currently taking single-dose vials of Zepbound. But Eli Lilly previously said that direct-to-consumer sales now account for more than a third of new prescriptions of Zepbound. 

Novo Nordisk earlier this month lowered the price of its obesity drug Wegovy and diabetes treatment Ozempic for existing cash-paying patients to $349 per month from $499 per month. That excludes the highest dose of Ozempic. 

The company also launched a temporary introductory offer, which will allow new cash-paying patients to access the two lowest doses of Wegovy and Ozempic for $199 per month for the first two months of treatment.